[Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
de la Cruz Amorós
E
E
Departamento de Pediatría, Hospital Clínico y Provincial de Barcelona.
Lambruschini Ferri
N
N
Rodríguez Miguélez
J M
JM
Torres Simón
J M
JM
D000493:Allopurinol / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007159:Immunologic Tests; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D013012:Sorbitol / Q000031:analogs & derivatives*
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009942:Organometallic Compounds; D013012:Sorbitol; D000493:Allopurinol; D008536:Meglumine; D000077485:Meglumine Antimoniate
Glucantime y alopurinol en el tratamiento de la leishmaniosis visceral infantil persistente.